NCT05127837

Brief Summary

The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
601

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

June 28, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 27, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

2.5 years

First QC Date

November 9, 2021

Results QC Date

November 24, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

Clinician TrainingAI (artificial Intelligence)Machine learningNLP (natural language processing)Cognitive Behavioral Therapy (CBT)

Outcome Measures

Primary Outcomes (1)

  • Revised Green Paranoid Thoughts Scale (R-GPTS) Mean Score

    The Revised Green Paranoid Thoughts Scale (R-GPTS) is a self-report measure of paranoid thinking over the past month, consisting of two validated subscales: Subscale A: Ideas of Reference (0-32) and Subscale B: Ideas of Persecution (0-40). Items are rated from 0 ("Not at all") to 4 ("Totally"), and each subscale is scored independently by summing item responses, with higher scores indicating greater severity. Scores ≥18 on the Persecution scale indicate clinically severe paranoid ideation. This measure was only collected and reported for client participants.

    0,3,6 months

Secondary Outcomes (2)

  • Change in CHOICE-SF (Choice of Outcome in CBT for Psychosis- Short Form)

    0,3,6 months

  • Change in in Sheehan Disability Scale (SDS) Mean Score

    0,3,6 months

Study Arms (2)

Treatment as Usual (TAU)

NO INTERVENTION

CBT for psychosis distance learning course.

CBTpro

EXPERIMENTAL

In addition to TAU, clinicians and clients receive the CBTpro training.

Behavioral: CBTpro

Interventions

CBTproBEHAVIORAL

CBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.

CBTpro

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

South Central Health and Rehabilitation Programs

Los Angeles, California, 90003, United States

Location

Psynergy

Morgan Hill, California, 93927, United States

Location

Telecare

San Jose, California, 95116, United States

Location

Integrated Services of Kalamazoo

Kalamazoo, Michigan, 49007, United States

Location

Community Mental Health Authority of Clinton, Eaton, and Ingham Counties (CEICMH)

Lansing, Michigan, 48823, United States

Location

Coleman Health Services

Akron, Ohio, 44223, United States

Location

PeaceHealth

Eugene, Oregon, 97401, United States

Location

Cascadia

Portland, Oregon, 97207, United States

Location

Lifeworks NW

Portland, Oregon, 97221, United States

Location

Harborview Medical Center

Seattle, Washington, 98104, United States

Location

Sound Health

Seattle, Washington, 98122, United States

Location

Frontier Behavioral Health

Spokane, Washington, 99208, United States

Location

Comprehensive Healthcare

Yakima, Washington, 98902, United States

Location

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaBipolar DisorderDepressive Disorder

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBipolar and Related DisordersMood Disorders

Results Point of Contact

Title
Sarah Kopelovich, PhD
Organization
University of Washington

Study Officials

  • Sarah Kopelovich, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

November 9, 2021

First Posted

November 19, 2021

Study Start

June 28, 2022

Primary Completion

December 9, 2024

Study Completion

December 9, 2024

Last Updated

February 27, 2026

Results First Posted

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Research subject's de-identified data will be shared through the National Institute of Mental Health Data Archive (NDA).

Locations